Journal
Clinical Gastroenterology and Hepatology
Publication Date
11-1-2025
Volume
23
Issue
12
First Page
2281
Last Page
2291.e4
Document Type
Open Access Publication
DOI
10.1016/j.cgh.2025.01.012
Rights and Permissions
Devi J, Xu A, Stone M, Patel A, Khan A, Reddy N, Klein J, Chowla N, Benson C, Luu BC, Huang K, Jaiprada F, Fenster M, Ungaro R, Pekow J, Johnson AM, Yarur AJ, Shukla R, Huecker J, Bishu S; REBOOT IBD Consortium; Deepak P. Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: A Multicenter Study. Clin Gastroenterol Hepatol. 2025 Nov;23(12):2281-2291.e4. doi: 10.1016/j.cgh.2025.01.012 © 2025 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Recommended Citation
Devi, Jalpa; Huang, Katherine; Jaiprada, Fnu; Huecker, Julia; Deepak, Parakkal; and et al., "Real-world effectiveness and safety of upadacitinib in Crohn's disease: A multicenter study." Clinical Gastroenterology and Hepatology. 23, 12. 2281 - 2291.e4. (2025).
https://digitalcommons.wustl.edu/oa_4/5594
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
